John Melki

Chief Executive Officer, Managing Director / Genetic Signatures

John Melki has authored 20 peer-reviewed articles and is listed as an inventor on eight patent applications. He worked in the sodium bisulphite conversion of DNA.

Dr Melki has led the commercialisation efforts of Genetic Signatures as chief executive since 2011. He joined the company in 2003 as a senior principal research scientist and was responsible for leading the commercialisation of 2 research products worldwide and 5 diagnostic products locally and in Europe.

Dr Melki received his Bachelor of Science from the University of New South Wales and his PhD from the University of Sydney where his thesis was awarded the Peter Bancroft Prize from the Medical School.

Lists and Charts

Roles

2011

Chief Executive Officer, Managing Director

Genetic Signatures

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
365^th	Toubani Resources	38.46%	0%
366^th	US Masters Residential Property Fund	38.26%	-13.57%
367^th	Genetic Signatures	38.23%	-8.88%
368^th	Westfield Innaloo	38.02%	21.57%
369^th	Westfield Whitford City	38.02%	21.57%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	REMUNERATION UPDATE: Chief Executive Officer, Managing Director, Genetic Signatures	13 Nov 2020
	NEW ROLE: Chief Executive Officer, Managing Director, Genetic Signatures	03 Nov 2020

Related Information

Access to our data for John Melki is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

John Melki is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.